Bladder Cancer Biomarker: Dogs & Humans – Early Detection

Here’s a breakdown of the information provided in the text:

1.Research Publication:

title: High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
Authors: Roberta Lucianò et al.
Journal: Frontiers in Oncology
Year: 2025
DOI: 10.3389/FONC.2025.1590073
Link: https://dx.doi.org/10.3389/fonc.2025.1590073

2. PHIRE Project Information:

Goal: To develop a high-resolution theranostic medical device for detecting and treating lesions smaller than 1mm.
Submission: Initially targeted for human bladder cancer, effective for both male and female patients.
Disclaimer: The views expressed are those of the author(s) and do not necessarily represent the views of the European Union or EISMEA (European Innovation and SME Executive Agency). The EU and granting authority are not responsible for the content.3. Citation (Print Only):

Topic: Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans.
* Year/month: 2025, September (incomplete citation – likely missing day)

In essence, this text describes a research finding about a shared biomarker in bladder cancer between dogs and humans, and it also promotes a project (PHIRE) aiming to create a new diagnostic/therapeutic device for bladder cancer.